These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 34159630

  • 1. Policy considerations for scaling up access to HIV pre-exposure prophylaxis for adolescent girls and young women: Examples from Kenya, South Africa, and Uganda.
    Lane J, Brezak A, Patel P, Verani AR, Benech I, Katz A.
    Int J Health Plann Manage; 2021 Sep; 36(5):1789-1808. PubMed ID: 34159630
    [Abstract] [Full Text] [Related]

  • 2. A community-based mobile clinic model delivering PrEP for HIV prevention to adolescent girls and young women in Cape Town, South Africa.
    Rousseau E, Bekker LG, Julies RF, Celum C, Morton J, Johnson R, Baeten JM, O'Malley G.
    BMC Health Serv Res; 2021 Aug 28; 21(1):888. PubMed ID: 34454505
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
    Nyblade L, Ndirangu JW, Speizer IS, Browne FA, Bonner CP, Minnis A, Kline TL, Ahmed K, Howard BN, Cox EN, Rinderle A, Wechsberg WM.
    BMC Public Health; 2022 Oct 14; 22(1):1916. PubMed ID: 36242000
    [Abstract] [Full Text] [Related]

  • 5. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
    Kayesu I, Mayanja Y, Nakirijja C, Machira YW, Price M, Seeley J, Siu G.
    BMC Womens Health; 2022 Nov 10; 22(1):440. PubMed ID: 36357920
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. From policy to practice: uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President's Emergency Plan for AIDS Relief-supported countries, 2017-2020.
    Patel P, Sato K, Bhandari N, Kanagasabai U, Schelar E, Cooney C, Eakle R, Klucking S, Toiv N, Saul J, PEPFAR PrEP stakeholders∗.
    AIDS; 2022 Jun 15; 36(Suppl 1):S15-S26. PubMed ID: 35766572
    [Abstract] [Full Text] [Related]

  • 9. Strengthening health system's capacity for pre-exposure prophylaxis for adolescent girls and young women and adolescent boys and young men in South Africa (SHeS'Cap-PrEP): Protocol for a mixed methods study in KwaZulu-Natal, South Africa.
    Nicol E, Ramraj T, Hlongwa M, Basera W, Jama N, Lombard C, McClinton-Appollis T, Govindasamy D, Pass D, Funani N, Aheron S, Paredes-Vincent A, Drummond J, Cheyip M, Dladla S, Bedford J, Mathews C.
    PLoS One; 2022 Jun 15; 17(3):e0264808. PubMed ID: 35298487
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The development of a conceptual framework on PrEP stigma among adolescent girls and young women in sub-Saharan Africa.
    Hartmann M, Nyblade L, Otticha S, Marton T, Agot K, Roberts ST.
    J Int AIDS Soc; 2024 Feb 15; 27(2):e26213. PubMed ID: 38379129
    [Abstract] [Full Text] [Related]

  • 15. Enhancing HIV pre-exposure prophylaxis outcomes among Kenyan adolescent girls and young women with a novel pharmacy-based PrEP delivery platform: protocol for a cluster-randomized controlled trial.
    Lagat HK, Pintye J, Harrington E, Houck S, Kwena Z, Lenn M, Mogaka F, Momanyi V, Mugambi M, Nyerere B, Odoyo J, Omollo V, Ortblad KF, Rota G, Sharma M, Bukusi EA.
    Trials; 2024 Jun 19; 25(1):394. PubMed ID: 38890744
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.
    Pretorius C, Schnure M, Dent J, Glaubius R, Mahiane G, Hamilton M, Reidy M, Matse S, Njeuhmeli E, Castor D, Kripke K.
    J Int AIDS Soc; 2020 Feb 19; 23(2):e25451. PubMed ID: 32112512
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.